A recent study identified aberrant allelic expression of both GNAS and HM13 at 20q11-13.32, as well as that of imprinted GRB10 at 7p12.1 and SNRPN 15q11.2 as useful biomarkers for lung cancer diagnosis [29]. This evidence concerns the gene GNAS and lung carcinoma.